Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • MedTrix Healthcare...

    MedTrix Healthcare plans to foray into US, EU markets

    Written by savita thakur thakur Published On 2016-04-18T13:52:06+05:30  |  Updated On 18 April 2016 1:52 PM IST
    MedTrix Healthcare plans to foray into US, EU markets

    Bengaluru : Digital and medical communications solutions provider MedTrix Healthcare plans to foray into the US and European Union (EU) markets to expand its operations following its tie-up with leading pharma companies.


    "We are planning to expand into multiple geographies by increasing our access to the top pharma firms and doubling the headcount," the city-based company said in a statement here on Sunday.


    The pharma sector is at its experimental phase in developing and deploying digital health solutions aimed at reaching HCPs (healthcare common procedures) and patients to improve disease outcomes.


    "Digital solutions are expected to result in 7-11 percent savings in total healthcare spending," MedTrix founder and director Vimal Narayanan said.


    The HCP codes are based on the American Medical Association's current procedural terminology.


    Among the company's global pharma clientele are Novartis, Bayer, Nestle, Eli Lilly, Pfizer, and Amgen. The company has also entered into strategic agreements with key clients in the US and EU markets to expand its footprint worldwide.


    "Until recently, though we have been engaging with some key clients in many projects in developed markets, most were in a pilot phase. Many of them have gone on to achieve successful metrics, prompting them to provide us with larger engagements," Narayanan noted.


    As a driver of the paradigm shifts in the pharma industry, the company plans engagements for professionals through digital route and production of digital assets for communications like apps, websites, videos and social media support.


    "With 6.9-billion dollar investments in digital solutions by global healthcare and pharma industry in 2015, we have begun to offer a berth for India in the growing space for others to follow," Narayanan added.


    The company also provides support to conceptualize, develop and launch new technologies to benefit patients and healthcare providers with measured return on investment.

    American Medical AssociationBayerHCPshealthcare common proceduresimprove disease outcomesMedTrixNestleNovartisPfizerVimal Narayanan
    Source : IANS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok